|
Market Closed -
Other stock markets
|
Pre-market 16:27:12 | |||
| 119.52 USD | -1.05% |
|
119.50 | -0.01% |
| 02:57pm | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 02:05pm | Cancer vaccines based on mRNA advance, despite US cuts | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.05% | +3.78% | +7.31% | +3.22% | +13.55% | +51.35% | +8.34% | +65.08% | +107.43% | 295B | |
| +0.36% | +5.39% | +22.05% | +28.01% | +12.40% | +18.90% | -18.24% | -10.84% | +52.75% | 69.01B | |
| -1.12% | +3.80% | +10.31% | +4.99% | +5.10% | +30.38% | +107.06% | +79.24% | +667.97% | 8.39B | |
| -1.06% | -1.37% | -1.97% | +6.18% | -7.50% | -4.94% | -13.57% | -35.78% | +18.90% | 7.72B | |
| -6.47% | -7.52% | -17.10% | -19.92% | -33.87% | -8.85% | +12.57% | -31.33% | - | 4.15B | |
| -6.58% | -13.19% | -16.40% | -27.09% | -35.59% | -30.25% | +24.42% | +31.37% | +62.57% | 3.47B | |
| +0.06% | -4.51% | -4.92% | +11.13% | +4.75% | -21.74% | -0.29% | -56.46% | - | 3.04B | |
| -0.60% | -0.63% | -13.68% | -17.43% | -10.50% | +34.18% | +24.98% | +48.12% | +126.82% | 2.58B | |
| -3.46% | -8.09% | -26.39% | -27.23% | -26.42% | -4.63% | -19.82% | -14.11% | - | 1.88B | |
| -0.67% | -3.99% | -7.39% | -17.82% | -11.88% | -17.21% | -21.24% | -13.51% | -38.51% | 1.76B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| -4.97% | -10.70% | -22.43% | -20.26% | -16.91% | +6.03% | +14.21% | -39.60% | - | 1.59B | |
| -2.58% | -7.00% | -31.55% | -20.95% | -11.74% | -3.24% | -24.79% | - | - | 1.25B | |
| -4.34% | -3.72% | -27.88% | -52.44% | -33.96% | +50.06% | +117.55% | +35.74% | +508.18% | 1.16B | |
| -3.40% | -6.97% | -19.32% | -9.29% | +0.61% | +83.62% | +63.46% | -28.78% | - | 1B | |
| -2.75% | +0.12% | -20.39% | -21.01% | -10.18% | +44.48% | +70.59% | +16.50% | +308.86% | 998M | |
| +1.05% | +3.35% | -13.45% | -15.72% | -16.99% | -8.42% | +32.46% | +81.56% | +66.02% | 988M | |
| -0.92% | -7.74% | -19.28% | -30.35% | -16.75% | +78.10% | -17.38% | -71.83% | -95.15% | 970M | |
| -1.81% | -8.21% | -20.81% | -22.57% | -22.32% | -30.57% | -76.13% | - | - | 895M | |
| -0.95% | -22.60% | -36.77% | -28.27% | -39.85% | -7.17% | -45.92% | -43.22% | - | 892M | |
| Average | -2.01% | -4.42% | -13.69% | -14.57% | -13.58% | +13.69% | +12.54% | +0.71% | +162.35% | 20.43B | |
| Weighted average by Cap. | -0.20% | +3.19% | +8.06% | +6.05% | +10.60% | +41.15% | +5.63% | +46.13% | +108.23% |
- Stock Market
- Stocks
- MRK Stock
- Sector Merck & Co., Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition